HR 4764 · 116th Congress · Health

TRANSPLANT Act of 2020

Introduced 2019-10-18· Sponsored by Rep. Matsui, Doris O. [D-CA-6]· House

Bill Progress

1
Introduced
Committee
House Vote
4
Senate
5
Enacted
Latest: Message on Senate action sent to the House.(2020-12-14)

Recorded Votes

PassedHouse · 2020-09-30
Roll #211
Yea 414Nay 0
Democrats
227 Yea·0 Nay
Republicans
186 Yea·0 Nay
PassedHouse · 2020-09-30
Roll #211
Yea 414Nay 0
Democrats
227 Yea·0 Nay
Republicans
186 Yea·0 Nay

How Did Your Rep Vote?

Enter a ZIP code or representative's name

Plain Language Summary

[AI summary unavailable — showing source text] Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2019 or the TRANSPLANT Act of 2019 This bill modifies and reauthorizes through FY2025 the C.W. Bill Young Cell Transplantation Program, which provides support to patients who need a potentially life-saving bone marrow transplant or umbilical cord blood transplant. The bill also requires the Department of Health and Human Services to conduct a periodic review of the science of using adult stem cells and birthing tissues in therapeutic treatments.…

Summarized by Claude AI · Non-partisan · For informational purposes only

CBO Cost Estimate

Congressional Budget Office

H.R. 4764, TRANSPLANT Act of 2019

Dec 24, 2020

As ordered reported by the House Committee on Energy and Commerce on September 9, 2020

Full CBO report ↗

Official non-partisan budget analysis by the Congressional Budget Office

Cosponsors (20)

14 Democrats6 Republicans